Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis

NCT02924701 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT02924701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02924701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2016
Completion date
September 30, 2031
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver inflammation, primary biliary cirrhosis